Related Experiment Video

Updated: Mar 28, 2026

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

8.5K

Targeting tumor microenvironment with PEG-based amphiphilic nanoparticles to overcome chemoresistance

Shizhu Chen1, Keni Yang2, Ruslan G Tuguntaev2

  • 1Key Laboratory of Chemical Biology of Hebei Province, Key Laboratory of Medicinal Chemistry and Molecular Diagnosis of the Ministry of Education, College of Chemistry & Environmental Science, Hebei University, Baoding, PR China.

Nanomedicine : Nanotechnology, Biology, and Medicine
|December 29, 2015
PubMed

Insights

Targeting the tumor microenvironment with PEG-based amphiphilic nanoparticles offers a promising strategy to overcome multidrug resistance in cancer. This approach enhances drug delivery systems for more effective cancer treatment.

Area of Science:

  • Oncology
  • Nanomedicine
  • Drug Delivery

Background:

  • Multidrug resistance is a major challenge in cancer therapy.
  • The tumor microenvironment significantly influences cancer progression and treatment resistance.
  • Novel strategies are needed to combat multidrug resistance in cancer.

Purpose of the Study:

  • To review the role of the tumor microenvironment in cancer.
  • To explore PEG-based amphiphilic nanoparticles for targeting the tumor microenvironment.
  • To discuss overcoming multidrug resistance in cancer using nanomedicine.

Main Methods:

  • Literature review on tumor microenvironment characteristics.
  • Analysis of PEG-based amphiphilic nanoparticle designs.
  • Examination of targeting mechanisms within the tumor microenvironment.

Main Results:

  • The tumor microenvironment is a key factor in cancer metastasis and drug resistance.
  • PEG-based amphiphilic nanoparticles show potential for targeted drug delivery.
  • Combining knowledge of the tumor microenvironment with nanoparticle design can address multidrug resistance.

Conclusions:

  • Targeting the tumor microenvironment is a viable strategy for cancer nanomedicine.
  • PEG-based amphiphilic nanoparticles offer a promising platform for overcoming multidrug resistance.
  • Further development of these drug delivery systems is crucial for improved cancer treatment.
Keywords:
Amphiphilic nanomaterialsCancer microenvironmentMultidrug resistancePoly(ethylene glycol)Tumor targeting

More Related Videos

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery09:09

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Published on: June 23, 2020

6.7K
Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

17.2K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.1K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.2K
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
109
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K